This site is intended for healthcare professionals
Respiratory Syncytial Virus (RSV) in Adults Learning Zone

Accredited eLearning

Read time: 60 mins
Last updated:25th Mar 2022
Published:25th Mar 2022

EACCME®-accredited eLearning

Receive 1 CME credit when you complete our interactive EACCME®-accredited eLearning module on addressing the unmet needs for respiratory syncytial virus (RSV) management in adults.

  • Discover the burden of RSV and which patients are most at risk of severe infection
  • Explore current diagnostic and treatment options for RSV infection, and their limitations
  • Understand the importance of infection control and the future of RSV prophylaxis

Addressing the unmet needs for RSV management in adults

This interactive EACCME®-accredited CME module is intended for healthcare professionals involved in the prevention and management of severe RSV infection in adults. Learn more about the diagnosis and impact of severe RSV infection, as well as current standard of care and ongoing vaccine development programmes.

Enrol

Section Content outline Time (60 mins total)
0 Introduction to the module 10 mins
1 RSV in adults 15 mins
2 Unmet needs in RSV management 15 mins
3 RSV infection prevention 15 mins
4 Survey and final result 5 mins

Course overview

How much do you know about the unmet needs for RSV management in adults? Put your knowledge to the test with the quizzes in our interactive EACCME®-accredited module, which includes information on the prevention, diagnosis, and treatment of severe RSV infection, with unmissable insights from RSV expert, Professor Harish Nair.

System Requirements

Meet the expert

Professor Harish Nair.pngProfessor Harish Nair

Chair of Paediatric Infectious Diseases and Global Health and leader of the Respiratory Viral Epidemiology research programme at the University pf Edinburgh. Professor Nair also leads the RSV Consortium in Europe (RESCEU) and the RSV Global Epidemiology Network (RSV GEN).

Disclosures: Grant support from Innovative Medicines Initiative, NIHR, Bill and Melinda Gates foundation, World Health Organisation and Pfizer; Honorary for participation on advisory boards from Sanofi Pasteur, ReViral, Janssen, Novavax; Speaker fees from Abbvie; Consultancy fees from GSK.

Further information

Evaluation questions will be asked at the end of the module. You must achieve a score of 70% or above to pass the course and receive your CME certificate.

At the end of the course, you will also be asked to complete a short survey, giving you the chance to provide feedback on your experience of the module.

On completion of this course, participants will understand:

  • the prevalence and burden of severe RSV infection in adults
  • risk factors for severe RSV in adults
  • current diagnostic, treatment, and prophylactic options for managing RSV infection
  • the importance of RSV infection control
  • clinical trial evidence for RSV vaccines in adults

Addressing the unmet needs for RSV management in adults

This interactive EACCME®-accredited CME module is intended for healthcare professionals involved in the prevention and management of severe RSV infection in adults. Learn more about the diagnosis and impact of severe RSV infection, as well as current standard of care and ongoing vaccine development programmes.

Enrol

Welcome: